Clinical Trial Update: High Dose Ascorbic Acid Treatment of CMT1A [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating high-dose ascorbic acid for Charcot-Marie-Tooth disease type 1A has completed Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease Type 1a

Drugs mentioned

• Ascorbic acid (high-dose) (ascorbic acid)

Snippet

Sponsor: Wayne State University | Conditions: Charcot-Marie-Tooth Disease, Type Ia | Phase 2, Phase 3 | Status: COMPLETED